logo
Share SHARE
FONT-SIZE Plus   Neg

Mylan's Generic Version Of Tricor Tablets For Cholesterol Gets FDA Approval

Generic drug maker Mylan Inc. (MYL: Quote), Friday said its unit Mylan Pharmaceuticals Inc. received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application or ANDA for the generic version of Abbvie Inc.'s (ABBV: Quote) cholesterol drug Tricor or Fenofibrate.

Mylan said that its unit Mylan Pharmaceuticals Inc. has shipped Fenofibrate Tablets, 48 mg and 145 mg. The drug is prescribed as an adjunctive therapy to diet to reduce elevated low-density lipoprotein cholesterol, total cholesterol, Triglycerides and apolipoprotein B, and to increase high-density lipoprotein cholesterol in adult patients. Fenofibrate Tablets also are indicated for treatment of adult patients with severe hypertriglyceridemia or high blood levels of triglycerides.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
If calories are not reduced, exercise alone can have no effect on obesity, says British Sports Medicine, a peer-reviewed journal of sport and exercise medicine. The journal says the blame for expanding waist lines is directly on the type and amount of calories consumed and the poor diet generates more disease than physical inactivity, alcohol and smoking combined. Deutsche Bank (DB) on Sunday reported an about 50 percent decline in first-quarter profit, despite clocking double-digit revenue growth, as the German lender recorded hefty legal charges over allegations of rate-rigging. Casino operator Wynn Resorts said its shareholders ousted Elaine Wynn from the board, reflecting fears that her presence may lead to disharmony with the management.
comments powered by Disqus
RELATED NEWS
Trade MYL now with 
Follow RTT